Silver Book Fact

Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s

Fact image

Scheiss M, Suescun J, Ellmore T, et al. Preliminary Report on the Safety and Tolerability of Bone Marrow-Derived Allogenic Mesenchymal Stem Cells Infused Intravenously in Parkinson’s Disease Patients; 2019. Accessed June 11, 2019


  • Innovative Medical Research
  • Human Value

Related Facts

  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • The present value QUALY gains associated with a new drug that by 2010 could delay disease onset by 1, 3, and 5 years. The dollar value estimates range from approximately…  
  • Medicare Costs, 5-Year Delayed Onset  
  • Medicaid Costs, Slowed Progression  
  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.